Sign in
4

Changes in Ownership

Celldex Therapeutics, Inc. Filed Acc 0001718112-26-000002

Options or other derivatives

  • SVP OF REGULATORY AFFAIRS acquired 95,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS 2026-06-25 Grant or award · Incentive Stock Option (right to buy) +95,000 95,000 D
Loading xslF345X06/form4-06292026_080629.xml…